Thomas Sandin
Physician Assistant · Marquette, MINPI 1356369870
Payments from drug & device makers
Across 143 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$673
- AbbVie$397
- Novartis$347
- Regeneron Healthcare Solutions, Inc.$328
- Sanofi$244
- E.r. Squibb & Sons, L.L.C.$217
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,89490%
- Education$32310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $673 |
| AbbVie | 21 | $397 |
| Novartis | 18 | $347 |
| Regeneron Healthcare Solutions, Inc. | 12 | $328 |
| Sanofi | 11 | $244 |
| E.r. Squibb & Sons, L.L.C. | 11 | $217 |
| UCB, Inc. | 8 | $194 |
| Sun Pharmaceutical Industries Inc. | 6 | $142 |
| Lilly USA, LLC | 6 | $126 |
| Amgen | 6 | $125 |
| LEO Pharma Inc. | 5 | $91 |
| Organogenesis Inc. | 3 | $88 |
| Pfizer | 3 | $72 |
| Incyte Corporation | 3 | $67 |
| Almirall LLC | 2 | $28 |
| Kyowa Kirin, Inc. | 1 | $22 |
| AstraZeneca | 1 | $22 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
| Krystal Biotech Inc | 1 | $16 |
How this compares
$3,217 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $161,547 |
| Dupixent PenDupilumab | 15 | $57,955 |
| Calcipotriene | 21 | $3,910 |
| Ketoconazole | 207 | $3,865 |
| Metronidazole | 59 | $2,696 |
| Betamethasone Dipropionate | 54 | $2,655 |
| Fluorouracil | 28 | $1,666 |
| Triamcinolone Acetonide | 166 | $1,424 |
| Minocycline Hcl | 57 | $1,149 |
| Clobetasol Propionate | 27 | $1,002 |
| Doxycycline Monohydrate | 36 | $942 |
| Clindamycin Phosphate | 41 | $643 |
| Mometasone Furoate | 15 | $435 |
| Doxycycline Hyclate | 43 | $416 |
| Fluocinolone Acetonide | 16 | $405 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Marquette
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.